Regulatory factors of basal F2-isoprostane formation: Population, age, gender and smoking habits in humans

Free Radical Research

Volumn 43, Issue 1, 2009, Pages 85-91

  Basu, Samar ^a,b   Helmersson, Johanna ^c   Jarosinska, Dorota ^d   Sällsten, Gerd ^e   Mazzolai, Barbarra ^f   Barregård, Lars ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d EUROPEAN ENVIRONMENT AGENCY   (Denmark)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Age; Demography; Gender; Humans; Isoprostanes; Oxidative stress; Population; Variation

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CREATININE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GEOGRAPHY; HUMAN; IN VIVO STUDY; ITALY; MALE; NORMAL HUMAN; OXIDATIVE STRESS; POLAND; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; SEX DIFFERENCE; SMOKING HABIT; SWEDEN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; F2-ISOPROSTANES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RADIOIMMUNOASSAY; SEX FACTORS; SMOKING;

EID: 63349101104     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802610851     Document Type: Article

References (33)

1. Halliwell, B. (2000) Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward?. Cardiovasc Res, 47, pp. 410-418.
2. Basu, S. (2004) Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radic Res, 38, pp. 105-122.
3. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr Opin Cell Biol, 15, pp. 247-254.
4. Basu, S. (2008) F2-Isoprostanes in human health and diseases: From molecular mechanisms to clinical implications. Antiox Redox Signal, 10, pp. 1405-1434.
5. Halliwell, B. and Grootveld, M. (1987) The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett, 213, pp. 9-14.
6. Morrow, JD, Harris, TM and Roberts, LJ 2nd (1990) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal Biochem, 184, pp. 1-10.
7. Kadiiska, MB, Gladen, BC, Baird, DD, Germolec, D., Graham, LB, Parker, CE, Nyska, A., Wachsman, JT, Ames, BN, Basu, S., Brot, N., Fitzgerald, GA, Floyd, RA, George, M., Heinecke, JW, Hatch, GE, Hensley, K., Lawson, JA, Marnett, LJ, Morrow, JD, Murray, DM, Plastaras, J., Roberts, LJ 2nd, Rokach, J., Shigenaga, MK, Sohal, RS, Sun, J., Tice, RR, Van Thiel, DH, Wellner, D., Walter, PB, Tomer, KB, Mason, RP and Barrett, JC. (2005) Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med, 38, pp. 698-710.
8. Basu, S. and Helmersson, J. (2005) Factors regulating isoprostane formation in vivo. Antiox Redox Signal, 7, pp. 221-235.
9. Morrow, JD. (2003) Is oxidant stress a connection between obesity and atherosclerosis?. Arteriosclerosis Thrombosis Vascular Biol, 23, pp. 368-370.
10. Barregard, L., Horvat, M., Mazzolai, B., Sallsten, G., Gibicar, D., Fajon, V., Dibona, S., Munthe, J., Wangberg, I. and Haeger Eugensson, M. (2006) Urinary mercury in people living near point sources of mercury emissions. Sci Total Environ, 368, pp. 326-334.
11. Jarosinska, D., Barregard, L., Biesiada, M., Muszynska-Graca, M., Dabkowska, B., Denby, B., Pacyna, J., Fudala, J. and Zielonka, U. (2006) Urinary mercury in adults in Poland living near a chloralkali plant. Sci Total Environ, 368, pp. 335-343.
12. Lauwerys, RHP. (1993) Industrial chemicals exposure. Guidelines for biological monitoring, Lewis Publishers, CRC Press, Boca raton, FL
13. Basu, S. (1998) Radioimmunoassay of 8-iso-prostaglandin F2alpha: An index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids, 58, pp. 319-325.
14. Keaney Jr, JF, Larson, MG, Vasan, RS, Wilson, PW, Lipinska, I., Corey, D., Massaro, JM, Sutherland, P., Vita, JA and Benjamin, EJ. (2003) Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis Thrombosis Vascular Biol, 23, pp. 434-439.
15. Richelle, M., Turini, ME, Guidoux, R., Tavazzi, I., Metairon, S. and Fay, LB. (1999) Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett, 459, pp. 259-262.
16. Reilly, M., Delanty, N., Lawson, JA and FitzGerald, GA. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 94, pp. 19-25.
17. Morrow, JD, Awad, JA, Kato, T., Takahashi, K., Badr, KF, Roberts, LJ 2nd and Burk, RF. (1992) Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest, 90, pp. 2502-2507.
18. Sodergren, E., Cederberg, J., Vessby, B. and Basu, S. (2001) Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats. Eur J Nutr, 40, pp. 10-16.
19. Sodergren, E., Vessby, B. and Basu, S. (2000) Radioimmunological measurement of F(2)-isoprostanes after hydrolysis of lipids in tissues. Prostaglandins Leukot Essent Fatty Acids, 63, pp. 149-152.
20. Ambring, A., Friberg, P., Axelsen, M., Laffrenzen, M., Taskinen, MR, Basu, S. and Johansson, M. (2004) Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci (Lond), 106, pp. 519-525.
21. Davi, G., Guagnano, MT, Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S. and Patrono, C. (2002) Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA, 288, pp. 2008-2014.
22. Silventoinen, K., Sans, S., Tolonen, H., Monterde, D., Kuulasmaa, K., Kesteloot, H. and Tuomilehto, J. (2004) Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord, 28, pp. 710-718.
23. Finkel, T. (2000) Redox-dependent signal transduction. FEBS Lett, 476, pp. 52-54.
24. Block, G., Dietrich, M., Norkus, EP, Morrow, JD, Hudes, M., Caan, B. and Packer, L. (2002) Factors associated with oxidative stress in human populations. Am J Epidemiol, 156, pp. 274-285.
25. Meghdadi, S., Rodrigues, M., Oguogho, A., Santler, R. and Sinzinger, H. (2003) 8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factors. Angiology, 54, pp. 317-324.
26. Vassalle, C., Botto, N., Andreassi, MG, Berti, S. and Biagini, A. (2003) Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis, 14, pp. 213-218.
27. Wang, Z., Ciabattoni, G., Creminon, C., Lawson, J., Fitzgerald, GA, Patrono, C. and Maclouf, J. (1995) Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther, 275, pp. 94-100.
28. Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H. and Takeshita, A. (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arteriosclerosis Thrombosis Vascular Biol, 22, pp. 438-442.
29. Helmersson, J., Mattsson, P. and Basu, S. (2002) Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine. Clin Sci (Lond), 102, pp. 39-43.
30. Ockene, IS and Miller, NH. (1997) Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation, 96, pp. 3243-3247.
31. Joseph, AM, Hecht, SS, Murphy, SE, Carmella, SG, Le, CT, Zhang, Y., Han, S. and Hatsukami, DK. (2005) Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev, 14, pp. 2963-2968.
32. Morrow, JD, Frei, B., Longmire, AW, Gaziano, JM, Lynch, SM, Shyr, Y., Strauss, WE, Oates, JA and Roberts, LJ 2nd (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med, 332, pp. 1198-1203.
33. Helmersson, J., Larsson, A., Vessby, B. and Basu, S. (2005) Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis, 181, pp. 201-207.